India’s Bharat Biotech will be producing part of the world’s only malaria vaccine that has been developed by Pharma major GSK, and was recently approved by WHO (World Health Organisation). However, it may take a couple of years before the vaccine is launched in the market for use. In January, this year, Hyderabad-based vaccine major announced that it entered a product transfer partnership with the pharma major GSK for its malaria vaccine, RTS, S/AS01E1.As part of this partnership, GSK would transfer RTS manufacturing technology to Bharat Biotech to produce the S antigen component of the malaria vaccine, and the license on all rights pertaining to it. GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to Bharat Biotech.
Related Articles
Bollywood
Sherlyn: Not settling scores, just ensuring no other woman becomes a victim
Actress and celebrity Sherlyn Chopra is miffed with the makers of the reality television show ‘Bigg Boss’ for including film director Sajid Khan, who was embroiled in the #MeToo controversy in India, back in 2018. […]
United States
ASPIRE PAC Endorses Sri Kulkarni; Indian American Candidate Running for Texas’ 22nd Congressional District
Houston (TIP) ASPIRE PAC, the political arm of Asian American and Pacific Islander Members of Congress, voted to endorse and support Indian American candidate Sri Kulkarni in his campaign for Texas’ 22nd Congressional District in the U.S. House […]
Entertainment
Halle Berry continues shooting for ‘Bruised’ despite two broken ribs
Hollywood star Halle Berry cracked two of her ribs on the first day of filming her new movie “Bruised” but that did not stop her from shooting, says her stunt coordinator. Berry will be seen […]

1 Trackback / Pingback